Trial Profile
Phase II study of BMS-986165 for the treatment of multiple immune-mediated disorders.
Planning
Phase of Trial:
Phase II
Latest Information Update: 25 Jan 2017
At a glance
- Drugs BMS 986165 (Primary)
- Indications Immunological disorders
- Focus Therapeutic Use
- 25 Jan 2017 New trial record